BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17192365)

  • 1. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Hirsch IB; Brownlee M
    Diabetes Care; 2007 Jan; 30(1):186-7; author reply 188-9. PubMed ID: 17192365
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Monnier L; Colette C; Leiter L; Ceriello A; Hanefeld M; Owens D; Tajima N; Tuomiletho J; Davidson J;
    Diabetes Care; 2007 Jan; 30(1):185-6; author reply 187-8. PubMed ID: 17192363
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Service FJ; O'Brien PC
    Diabetes Care; 2007 Jan; 30(1):186; author reply 187-8. PubMed ID: 17192366
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Diabetes Reserach in Children Network (DirecNet) Study Group
    Diabetes Care; 2007 Jan; 30(1):185; author reply 187-9. PubMed ID: 17192364
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of glycemic equilibrium on micro-angiopathic complications in insulin-dependent diabetes: results of recent studies].
    Zinman B
    Journ Annu Diabetol Hotel Dieu; 1994; ():93-100. PubMed ID: 8051834
    [No Abstract]   [Full Text] [Related]  

  • 6. For debate. Glucose variability and diabetes complication risk: we need to know the answer.
    Kilpatrick ES; Rigby AS; Atkin SL
    Diabet Med; 2010 Aug; 27(8):868-71. PubMed ID: 20653742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological aspects of diabetic angiopathies pathogenesis].
    Galenok VA; Zhuk EA
    Ter Arkh; 1998; 70(10):5-10. PubMed ID: 9864794
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose variability, blood pressure and arterial stiffness in type 1 diabetes.
    Gordin D; Rönnback M; Forsblom C; Mäkinen V; Saraheimo M; Groop PH
    Diabetes Res Clin Pract; 2008 Jun; 80(3):e4-7. PubMed ID: 18325620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early vascular risk factor modification in type 1 diabetes.
    Perkins BA; Bril V
    N Engl J Med; 2005 Jan; 352(4):408-9. PubMed ID: 15673807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Etiology of diabetic microangiopathy. Is the glucose level everything?].
    Rosenlund BL
    Tidsskr Nor Laegeforen; 1994 Mar; 114(7):826-7. PubMed ID: 8009505
    [No Abstract]   [Full Text] [Related]  

  • 11. Near-normoglycaemia and microvascular complications.
    Mühlhauser I; Bruckner J; Howorka K
    Diabetologia; 1987 Jan; 30(1):47-8. PubMed ID: 3552820
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intensified treatment of diabetes prevents complications].
    Koivisto V
    Duodecim; 1993; 109(19):1622-4. PubMed ID: 7736979
    [No Abstract]   [Full Text] [Related]  

  • 13. Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
    Stevanovic RD; Fisher ND; Lansang CM; Freeman KD; Hollenberg NK
    J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):85-92. PubMed ID: 17703435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normoglycaemic re-entry and diabetic complications.
    Keen H
    Diabet Med; 1984 Jul; 1(2):85-7. PubMed ID: 6242792
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoprotein (a): role in diabetes and its vascular complications.
    Mohan A; Srinivasan V; Deepa R; Mohan V
    J Assoc Physicians India; 2001 Nov; 49():1100-5. PubMed ID: 11868866
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose variability and complications.
    Bolli GB
    Diabetes Care; 2006 Jul; 29(7):1707-9. PubMed ID: 16801607
    [No Abstract]   [Full Text] [Related]  

  • 17. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes: response to Dyck et al.
    Orchard TJ; Costacou T; Miller RG; Prince CT; Pambianco G
    Diabetes Care; 2007 Feb; 30(2):448; author reply 448-9. PubMed ID: 17259536
    [No Abstract]   [Full Text] [Related]  

  • 18. [Follow-up of the type 2 diabetic patient excluding follow-up of complications. Recommendations of ANAES].
    Diabetes Metab; 1999 Mar; 25 Suppl 2():1-64. PubMed ID: 10226757
    [No Abstract]   [Full Text] [Related]  

  • 19. Eating disorders and diabetic complications.
    Williams G; Gill GV
    N Engl J Med; 1997 Jun; 336(26):1905-6. PubMed ID: 9197220
    [No Abstract]   [Full Text] [Related]  

  • 20. A method for assessing quality of control from glucose profiles.
    Hill NR; Hindmarsh PC; Stevens RJ; Stratton IM; Levy JC; Matthews DR
    Diabet Med; 2007 Jul; 24(7):753-8. PubMed ID: 17459094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.